Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350644
Max Phase: Preclinical
Molecular Formula: C12H20N5O13P3
Molecular Weight: 535.24
Molecule Type: Small molecule
Associated Items:
ID: ALA3350644
Max Phase: Preclinical
Molecular Formula: C12H20N5O13P3
Molecular Weight: 535.24
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C1C(=O)NC(=O)N([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COCP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)C1C
Standard InChI: InChI=1S/C12H20N5O13P3/c1-6-7(2)17(12(19)14-11(6)18)10-3-8(15-16-13)9(28-10)4-27-5-31(20,21)29-33(25,26)30-32(22,23)24/h7-10H,1,3-5H2,2H3,(H,20,21)(H,25,26)(H,14,18,19)(H2,22,23,24)/t7?,8-,9+,10+/m0/s1
Standard InChI Key: UVIUBXKVDCKKBS-HCZOVWHVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 535.24 | Molecular Weight (Monoisotopic): 535.0270 | AlogP: 0.66 | #Rotatable Bonds: 10 |
Polar Surface Area: 267.22 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -10.24 | CX Basic pKa: | CX LogP: -1.37 | CX LogD: -8.66 |
Aromatic Rings: 0 | Heavy Atoms: 33 | QED Weighted: 0.08 | Np Likeness Score: 1.04 |
1. Jie L, Van Aerschot A, Balzarini J, Janssen G, Busson R, Hoogmartens J, De Clercq E, Herdewijn P.. (1990) 5'-O-phosphonomethyl-2',3'-dideoxynucleosides: synthesis and anti-HIV activity., 33 (9): [PMID:1697345] [10.1021/jm00171a023] |
Source(1):